Kyle Guse - 14 May 2021 Form 4 Insider Report for ATOSSA THERAPEUTICS, INC. (ATOS)

Role
CFO, Gen Counsel and Secretary
Signature
/s/ Kyle Guse
Issuer symbol
ATOS
Transactions as of
14 May 2021
Transactions value $
$0
Form type
4
Filing time
18 May 2021, 16:18:45 UTC
Next filing
28 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATOS Stock Option (right to buy) Award $0 +850K $0.00 850K 14 May 2021 Common Stock 850K $2.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest on a quarterly basis over the next 24 months. Option grant was issued at 4:30 p.m. (ET) on May 14, 2021 with an exercise price of $2.90, representing the most recently reported closing stock price at the time of grant.